查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1594481

神經血栓清除裝置市場：依產品、治療應用及最終用途 – 2025-2030 年全球預測

Neurothrombectomy Devices Market by Product, Therapeutic Application (Arteriovenous Malformations & AV Fistulas, Cerebral Aneurysms, Cerebral Artery Stenosis), End-Use - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 199 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年神經血栓切除設備市場價值為7.8001億美元，預計到2024年將達到8.75億美元，複合年成長率為12.66%，預計到2030年將達到17.9713億美元。

神經血栓切除裝置對於治療急性缺血性腦中風至關重要，用於物理清除腦動脈中的血栓。由於人口老化以及糖尿病和高血壓等與文明病的增加，全球中風的發病率不斷增加，因此這一點的必要性得到了強調。其應用範圍擴展到醫院和神經科科診所等醫療機構，最終用戶是專門從事神經病學和介入放射學的醫療專業人員。市場成長主要由技術進步推動，例如開發具有更高準確性和安全性的下一代檢索器和抽吸裝置。最近，政府加大對中風管理的支持和有利的報銷政策提供了有利可圖的機會。然而，該市場因設備和程序的高成本以及缺乏熟練的專業人員來操作而受到阻礙，特別是在新興市場。機會在於開拓具有成本效益的解決方案並擴大進入亞洲和非洲開拓市場的機會。該領域的創新可以集中在設備小型化上，以提高可操作性，以及開發人工智慧驅動的診斷和手術工具，以支援快速、準確地清除血栓。市場相關人員還應考慮與政府機構和醫療保健組織合作，加強對臨床醫生的培訓計畫。然而，來自藥物溶栓等替代療法的競爭以及嚴格的監管政策是持續的挑戰。儘管面臨這些挑戰，在持續的研發投資和策略夥伴關係關係的推動下，神經血栓切除術市場預計將顯著成長。創新者應專注於提高設備功效和患者治療效果，還可以探索奈米技術和生物感測器的整合。總體而言，市場是動態的，具有巨大的創新和策略性擴張空間，以滿足對改善中風治療和介入措施不斷成長的需求。

主要市場統計
基準年[2023] 78001萬美元
預測年份 [2024] 8.75 億美元
預測年份 [2030] 1,797.13 百萬美元
複合年成長率（%） 12.66%

市場動態：揭示快速發展的神經血栓清除設備市場的關鍵市場洞察

供需的動態交互作用正在改變神經血栓切除術設備市場。透過了解這些不斷變化的市場動態，公司可以準備好做出明智的投資決策、完善策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時也能幫助企業了解消費行為及其對製造業的影響。

  • 市場促進因素
    • 全球急性缺血性腦中風增加
    • 世界各國政府為預防中風所做的努力
    • 提高大眾對神經血栓切除的認知
  • 市場限制因素
    • 嚴格而複雜的法律規範
  • 市場機會
    • 擴大先進神經血栓清除裝置的開發
    • 市場參與企業增加投資和贖回政策的可用性
  • 市場問題
    • 與神經血栓切除裝置相關的風險

波特五力：駕馭神經血栓切除設備市場的策略工具

波特的五力框架是了解神經血栓切除設備市場競爭格局的關鍵工具。波特的五力框架描述了評估公司競爭和探索策略機會的清晰方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解神經血栓清除設備市場的外部影響

外部宏觀環境因素在塑造神經血栓切除設備市場的績效動態發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並為他們做出積極主動的決策做好準備。

市場佔有率分析：了解神經血栓切除設備市場的競爭狀況

對神經血栓切除術設備市場的詳細市場佔有率分析可以對供應商的績效進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、細分和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV 定位矩陣：神經血栓切除設備市場供應商的績效評估

FPNV 定位矩陣是評估神經血栓切除設備市場供應商的關鍵工具。此矩陣允許業務組織根據供應商的商務策略和產品滿意度評估供應商，從而做出符合其目標的明智決策。這四個象限使您能夠清晰、準確地分類供應商，以確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析與建議：繪製神經血栓清除設備市場的成功之路

對於旨在加強其在全球市場的影響力的公司來說，對神經血栓切除術設備市場的策略分析至關重要。透過考慮關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機並取得長期成功。

該報告對涵蓋關鍵焦點細分市場的市場進行了全面分析。

1. 市場滲透率：詳細檢視當前市場環境，主要企業的廣泛資料，評估其在市場中的影響力和整體影響力。

2. 市場開拓：辨識新興市場的成長機會，評估現有細分市場的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5.產品開發與創新：重點關注可望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，以幫助相關人員做出明智的決策。

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品和地區提供最佳投資機會？

3.塑造市場的關鍵技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 全球急性缺血性腦中風的發生率增加
      • 世界各國政府為預防中風所做的努力
      • 提高大眾對神經血栓切除的認知
    • 抑制因素
      • 嚴格而複雜的法規結構
    • 機會
      • 擴大先進神經血栓切除設備的開發
      • 市場參與企業增加投資和贖回政策的可用性
    • 任務
      • 與神經血栓切除裝置相關的風險
  • 市場區隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治
    • 經濟
    • 社會
    • 科技
    • 法律
    • 環境

第6章神經血栓切除設備市場：依產品

  • 介紹
  • 吸引裝置
  • 凝結獵犬
  • 勒除器

第7章神經血栓清除裝置市場：依治療應用分類

  • 介紹
  • 動靜脈畸形 (AVM) 和 AV 瘻管
  • 腦動脈瘤
  • 腦動脈狹窄
  • 缺血性中風

第8章神經血栓清除裝置市場：依最終用途分類

  • 介紹
  • 門診手術中心
  • 急診室
  • 醫院

第9章北美及南美神經血栓清除裝置市場

  • 介紹
  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第10章亞太神經血栓切除術設備市場

  • 介紹
  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第11章歐洲/中東/非洲神經血栓切除術設備市場

  • 介紹
  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第12章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
  • 戰略分析和建議

公司名單

  • Abbott Laboratories
  • Acandis GmbH
  • Argon Medical Devices, Inc.
  • Boston Scientific Corporation
  • Edwards Lifesciences Corporation
  • Johnson & Johnson Services, Inc.
  • Koninklijke Philips NV
  • Medtronic Plc
  • NeuroVasc Technologies, Inc.
  • Penumbra, Inc.
  • Stryker Corporation
  • Teleflex Incorporated
  • Terumo Corporation
  • Vesalio, LLC
Product Code: MRR-8C74ADFC1598

The Neurothrombectomy Devices Market was valued at USD 780.01 million in 2023, expected to reach USD 875.00 million in 2024, and is projected to grow at a CAGR of 12.66%, to USD 1,797.13 million by 2030.

Neurothrombectomy devices are integral in the treatment of acute ischemic strokes, employed to physically remove blood clots from cerebral arteries. The necessity of these devices is underscored by the rising incidence of strokes globally, coupled with an aging population and increasing prevalence of lifestyle diseases like diabetes and hypertension. Their application spans healthcare facilities such as hospitals and specialty neurology clinics, with end-users being healthcare professionals specializing in neurology and interventional radiology. Market growth is primarily driven by advancements in technology, including the development of next-generation retrievers and aspiration devices that offer increased precision and safety. Recently, increasing government support for stroke management, alongside favorable reimbursement policies, presents lucrative opportunities. However, market constraints include the high cost of devices and procedures, coupled with a dearth of skilled professionals to operate them, especially in developing regions. Opportunities lie in developing cost-effective solutions and expanding reach to untapped markets in Asia and Africa. Innovations in the field may focus on miniaturization of devices for enhanced maneuverability and development of AI-powered diagnostic and surgical tools to support swift and precise clot removal. Market players should also consider collaboration with government bodies and health organizations to enhance training programs for clinicians. Nonetheless, stringent regulatory policies pose ongoing challenges, alongside the competition from alternative therapies like pharmacological thrombolysis. Despite these challenges, the neurothrombectomy market is expected to witness substantial growth, fueled by continuous R&D investments and strategic partnerships. Innovators should focus on improving device efficacy and patient outcomes, potentially exploring the integration of nanotechnology and biosensor advancements. Overall, the market is dynamic, with substantial scope for innovation and strategic expansion to cater to the growing demand for improved stroke treatments and interventions.

KEY MARKET STATISTICS
Base Year [2023] USD 780.01 million
Estimated Year [2024] USD 875.00 million
Forecast Year [2030] USD 1,797.13 million
CAGR (%) 12.66%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Neurothrombectomy Devices Market

The Neurothrombectomy Devices Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Rising incidences of acute ischemic stroke globally
    • Initiatives by government worldwide for the prevention of stroke
    • Growing awareness about the neurothrombectomy among the population
  • Market Restraints
    • Stringent and complex regulatory framework
  • Market Opportunities
    • Growing development of advanced neurothrombectomy devices
    • Increasing investments by market players and availability of reimbursement policies
  • Market Challenges
    • Risks associated with the neurothrombectomy devices

Porter's Five Forces: A Strategic Tool for Navigating the Neurothrombectomy Devices Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Neurothrombectomy Devices Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Neurothrombectomy Devices Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Neurothrombectomy Devices Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Neurothrombectomy Devices Market

A detailed market share analysis in the Neurothrombectomy Devices Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Neurothrombectomy Devices Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Neurothrombectomy Devices Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Neurothrombectomy Devices Market

A strategic analysis of the Neurothrombectomy Devices Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Neurothrombectomy Devices Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Acandis GmbH, Argon Medical Devices, Inc., Boston Scientific Corporation, Edwards Lifesciences Corporation, Johnson & Johnson Services, Inc., Koninklijke Philips N.V., Medtronic Plc, NeuroVasc Technologies, Inc., Penumbra, Inc., Stryker Corporation, Teleflex Incorporated, Terumo Corporation, and Vesalio, LLC.

Market Segmentation & Coverage

This research report categorizes the Neurothrombectomy Devices Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product, market is studied across Aspiration/Suction Devices, Clot Retrievers, and Vascular Snares.
  • Based on Therapeutic Application, market is studied across Arteriovenous Malformations (AVMs) & AV Fistulas, Cerebral Aneurysms, Cerebral Artery Stenosis, and Ischemic Stroke.
  • Based on End-Use, market is studied across Ambulatory Surgical Centers, Emergency Clinics, and Hospitals.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising incidences of acute ischemic stroke globally
      • 5.1.1.2. Initiatives by government worldwide for the prevention of stroke
      • 5.1.1.3. Growing awareness about the neurothrombectomy among the population
    • 5.1.2. Restraints
      • 5.1.2.1. Stringent and complex regulatory framework
    • 5.1.3. Opportunities
      • 5.1.3.1. Growing development of advanced neurothrombectomy devices
      • 5.1.3.2. Increasing investments by market players and availability of reimbursement policies
    • 5.1.4. Challenges
      • 5.1.4.1. Risks associated with the neurothrombectomy devices
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Neurothrombectomy Devices Market, by Product

  • 6.1. Introduction
  • 6.2. Aspiration/Suction Devices
  • 6.3. Clot Retrievers
  • 6.4. Vascular Snares

7. Neurothrombectomy Devices Market, by Therapeutic Application

  • 7.1. Introduction
  • 7.2. Arteriovenous Malformations (AVMs) & AV Fistulas
  • 7.3. Cerebral Aneurysms
  • 7.4. Cerebral Artery Stenosis
  • 7.5. Ischemic Stroke

8. Neurothrombectomy Devices Market, by End-Use

  • 8.1. Introduction
  • 8.2. Ambulatory Surgical Centers
  • 8.3. Emergency Clinics
  • 8.4. Hospitals

9. Americas Neurothrombectomy Devices Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Neurothrombectomy Devices Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Neurothrombectomy Devices Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Abbott Laboratories
  • 2. Acandis GmbH
  • 3. Argon Medical Devices, Inc.
  • 4. Boston Scientific Corporation
  • 5. Edwards Lifesciences Corporation
  • 6. Johnson & Johnson Services, Inc.
  • 7. Koninklijke Philips N.V.
  • 8. Medtronic Plc
  • 9. NeuroVasc Technologies, Inc.
  • 10. Penumbra, Inc.
  • 11. Stryker Corporation
  • 12. Teleflex Incorporated
  • 13. Terumo Corporation
  • 14. Vesalio, LLC

LIST OF FIGURES

  • FIGURE 1. NEUROTHROMBECTOMY DEVICES MARKET RESEARCH PROCESS
  • FIGURE 2. NEUROTHROMBECTOMY DEVICES MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY THERAPEUTIC APPLICATION, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY THERAPEUTIC APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY END-USE, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY END-USE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 13. AMERICAS NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. UNITED STATES NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 15. UNITED STATES NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. ASIA-PACIFIC NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. NEUROTHROMBECTOMY DEVICES MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 21. NEUROTHROMBECTOMY DEVICES MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. NEUROTHROMBECTOMY DEVICES MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. NEUROTHROMBECTOMY DEVICES MARKET DYNAMICS
  • TABLE 7. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY ASPIRATION/SUCTION DEVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY CLOT RETRIEVERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY VASCULAR SNARES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY ARTERIOVENOUS MALFORMATIONS (AVMS) & AV FISTULAS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY CEREBRAL ANEURYSMS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY CEREBRAL ARTERY STENOSIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY ISCHEMIC STROKE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY EMERGENCY CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. AMERICAS NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 21. AMERICAS NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 22. AMERICAS NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 23. AMERICAS NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 24. ARGENTINA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 25. ARGENTINA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 26. ARGENTINA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 27. BRAZIL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 28. BRAZIL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 29. BRAZIL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 30. CANADA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 31. CANADA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 32. CANADA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 33. MEXICO NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 34. MEXICO NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 35. MEXICO NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 36. UNITED STATES NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 37. UNITED STATES NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 38. UNITED STATES NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 39. UNITED STATES NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 40. ASIA-PACIFIC NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 41. ASIA-PACIFIC NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 42. ASIA-PACIFIC NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 43. ASIA-PACIFIC NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 44. AUSTRALIA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 45. AUSTRALIA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 46. AUSTRALIA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 47. CHINA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 48. CHINA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 49. CHINA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 50. INDIA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 51. INDIA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 52. INDIA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 53. INDONESIA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 54. INDONESIA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 55. INDONESIA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 56. JAPAN NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 57. JAPAN NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 58. JAPAN NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 59. MALAYSIA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 60. MALAYSIA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 61. MALAYSIA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 62. PHILIPPINES NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 63. PHILIPPINES NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 64. PHILIPPINES NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 65. SINGAPORE NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 66. SINGAPORE NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 67. SINGAPORE NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 68. SOUTH KOREA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 69. SOUTH KOREA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 70. SOUTH KOREA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 71. TAIWAN NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 72. TAIWAN NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 73. TAIWAN NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 74. THAILAND NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 75. THAILAND NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 76. THAILAND NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 77. VIETNAM NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 78. VIETNAM NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 79. VIETNAM NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 80. EUROPE, MIDDLE EAST & AFRICA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 81. EUROPE, MIDDLE EAST & AFRICA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 82. EUROPE, MIDDLE EAST & AFRICA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 83. EUROPE, MIDDLE EAST & AFRICA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 84. DENMARK NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 85. DENMARK NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 86. DENMARK NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 87. EGYPT NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 88. EGYPT NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 89. EGYPT NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 90. FINLAND NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 91. FINLAND NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 92. FINLAND NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 93. FRANCE NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 94. FRANCE NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 95. FRANCE NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 96. GERMANY NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 97. GERMANY NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 98. GERMANY NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 99. ISRAEL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 100. ISRAEL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 101. ISRAEL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 102. ITALY NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 103. ITALY NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 104. ITALY NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 105. NETHERLANDS NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 106. NETHERLANDS NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 107. NETHERLANDS NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 108. NIGERIA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 109. NIGERIA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 110. NIGERIA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 111. NORWAY NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 112. NORWAY NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 113. NORWAY NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 114. POLAND NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 115. POLAND NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 116. POLAND NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 117. QATAR NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 118. QATAR NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 119. QATAR NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 120. RUSSIA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 121. RUSSIA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 122. RUSSIA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 123. SAUDI ARABIA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 124. SAUDI ARABIA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 125. SAUDI ARABIA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 126. SOUTH AFRICA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 127. SOUTH AFRICA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 128. SOUTH AFRICA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 129. SPAIN NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 130. SPAIN NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 131. SPAIN NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 132. SWEDEN NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 133. SWEDEN NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 134. SWEDEN NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 135. SWITZERLAND NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 136. SWITZERLAND NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 137. SWITZERLAND NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 138. TURKEY NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 139. TURKEY NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 140. TURKEY NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 141. UNITED ARAB EMIRATES NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 142. UNITED ARAB EMIRATES NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 143. UNITED ARAB EMIRATES NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 144. UNITED KINGDOM NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 145. UNITED KINGDOM NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 146. UNITED KINGDOM NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 147. NEUROTHROMBECTOMY DEVICES MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 148. NEUROTHROMBECTOMY DEVICES MARKET, FPNV POSITIONING MATRIX, 2023